Key facts
- It has raised $6.0M; the latest was Early Stage VC ($6.0M) in Sep 2025.
- Notable investors include India Quotient, Stellaris Venture Partners.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for PlatinumRx
- ·The full record, as it builds
Funding rounds
No funding rounds for PlatinumRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PlatinumRx
Operator of a pharma industry online platform intended to order medicines without middlemen. The company's platform sources substitute medicines from brands that contain the same salt composition and dosage, enabling patients to get medicine from the comfort of their homes.
- Sector
- Healthcare
- HQ
- Bengaluru, India
- Founded
- 2023
- Employees
- 16
- Website
- platinumrx.in/
- Ownership
- Privately Held (backing)
PlatinumRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PlatinumRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PlatinumRx in its N-PORT filings yet. We sweep new filings monthly.